The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target (vol 30, pg 726, 2022)

被引:0
|
作者
Verma, Ankit
Pittala, Srinivas
Alhozeel, Belal
Shteinfer-Kuzmine, Anna
Ohana, Ehud
Gupta, Rajeev
Chung, Jay H.
Shoshan-Barmatz, Varda
机构
关键词
D O I
10.1016/j.ymthe.2024.03.013
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1178 / 1178
页数:1
相关论文
共 50 条
  • [31] The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease
    Wang, Lijian
    Trebicka, Estela
    Fu, Ying
    Ellenbogen, Shiri
    Hong, Charles C.
    Babitt, Jodie L.
    Lin, Herbert Y.
    Cherayil, Bobby J.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (01) : 112 - 119
  • [32] LXR-ABCA1 pathway: a therapeutic target in inflammatory bowel disease?
    Miranda-Bautista, J.
    Rodriguez-Feo, J. A.
    Lopez Cauce, B.
    Puerto, M.
    Lara, J. M.
    Banares, R.
    Menchen, L.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S149 - S150
  • [33] Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease
    Naito, Y
    Takagi, T
    Yoshikawa, T
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 177 - 184
  • [34] The Emerging Role of Leptin Antagonist as Potential Therapeutic Option for Inflammatory Bowel Disease
    Singh, Udai P.
    Singh, Narendra P.
    Guan, Hongbing
    Busbee, Brandon
    Price, Robert L.
    Taub, Dennis D.
    Mishra, Manoj K.
    Fayad, Raja
    Nagarkatti, Mitzi
    Nagarkatti, Prakash S.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2014, 33 (01) : 23 - 33
  • [35] Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
    Ankit Verma
    Anna Shteinfer-Kuzmine
    Nikita Kamenetsky
    Srinivas Pittala
    Avijit Paul
    Edna Nahon Crystal
    Alberto Ouro
    Vered Chalifa-Caspi
    Swaroop Kumar Pandey
    Alon Monsonego
    Noga Vardi
    Shira Knafo
    Varda Shoshan-Barmatz
    Translational Neurodegeneration, 12
  • [36] Ultrasonography in inflammatory bowel disease - so far we are? (vol 10, pg 225, 2022)
    Maaser, Christian
    Maconi, Giovanni
    Kucharzik, Torsten
    Allocca, Mariangela
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2022, 10 (04) : 439 - 439
  • [37] DEL-1: a potential therapeutic target in inflammatory and autoimmune disease?
    Hajishengallis, George
    Chavakis, Triantafyllos
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (06) : 549 - 552
  • [38] Plasma IgA as a biomarker and IL-21 as a potential therapeutic target in Inflammatory Bowel Disease
    Tsai, T.
    Hsu, J. L.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I981 - I982
  • [39] TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease
    Furfaro, Federica
    Alfarone, Ludovico
    Gilardi, Daniela
    Correale, Carmen
    Allocca, Mariangela
    Fiorino, Gionata
    Argollo, Marjorie
    Zilli, Alessandra
    Zacharopoulou, Eirini
    Loy, Laura
    Roda, Giulia
    Danese, Silvio
    CURRENT DRUG TARGETS, 2021, 22 (07) : 760 - 769
  • [40] 4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation (vol 47, pg 3385, 2022)
    Tiwari, Shubhangini
    Gupta, Parul
    Singh, Abhishek
    Chaturvedi, Swati
    Wahajuddin, M.
    Mishra, Amit
    Singh, Sarika
    NEUROCHEMICAL RESEARCH, 2023, 48 (10) : 3251 - 3252